The effects of intravenous dexmedetomidine premedication on induction of anaesthesia using target-controlled infusion of propofol and remifentanil by Ab Aziz, Siti Nur Amani
i 
  
THE EFFECTS OF 
INTRAVENOUS DEXMEDETOMIDINE PREMEDICATION 
ON INDUCTION OF ANAESTHESIA 
USING TARGET-CONTROLLED INFUSION OF 
PROPOFOL AND REMIFENTANIL 
 
 
DR SITI NUR AMANI AB AZIZ 
 
 
DISSERTATION SUBMITTED IN 
PARTIAL FULFILMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF MASTER OF MEDICINE 
(ANAESTHESIOLOGY) 
 
 
 
 
UNIVERSITI SAINS MALAYSIA  
2016 
 
 
 
ii 
  
THE EFFECTS OF INTRAVENOUS DEXMEDETOMIDINE PREMEDICATION  
ON INDUCTION OF ANAESTHESIA  
USING TARGET-CONTROLLED INFUSION OF  
PROPOFOL AND REMIFENTANIL            
 
 
 
   
   
 
 
DR SITI NUR AMANI AB AZIZ 
 
 
 
 
 
Dissertation submitted in  
partial fulfilment of the requirements  
for the Degree of Master of Medicine (Anaesthesiology) 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA  
2016 
 
iii 
  
ACKNOWLEDGEMENTS 
 
 
With the name of Allah, Most Gracious Most Merciful again, for His blessings in the 
completion of this thesis to fulfil the requirement for the degree in anaesthesiology.  
I would like to say thank you and a bouquet of appreciation to; 
 Dr W Mohd Nazaruddin W Hassan, my dedicated supervisor. His 
determination and passion inspired me to keep moving forward. 
 Prof Dr Shamsul Kamalrujan Hassan, my never ending motivator, and co-
supervisor. His words helped me ease the chaotic hassle to complete this 
programme.   
 Miss Siti Nur Farliza Zaharudin, a statistician, who always welcomed me 
throughout the preparation of this dissertation especially in the statistical 
analysis.  
 All staff in Operation Theatre for their full cooperation.  
 Mr Luqman Ahmad, my life-companion. His words of courage never failed to 
bring smiles.  
 Abi and Umi, my beloved parents. Their support is never ending.  
 My sisters, Lana and Liya, both of you are a good commenter.   
 
 
 
 
iv 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
iii 
  
TABLE OF CONTENTS  
 
 
  
Title page           i 
Acknowledgements          ii 
Table of contents          iii 
List of tables           ix 
List of figures          xi 
Abbreviations          xii 
Abstrak           xiii 
Abstract           xvi 
CHAPTER 1: INTRODUCTION        1 
CHAPTER 2: LITERATURE REVIEW       7 
2.0 INTRODUCTION OF ANAESTHESIA      7 
 2.0.1 THE HISTORY AND DEFINITION OF ANAESTHESIA  7 
           2.0.2 TYPES OF ANAESTHESIA AND AIMS DURING     
ANAESTHESIA        9 
           2.0.3 GENERAL ANAESTHETIC AGENTS IN CLINICAL USE  10 
           2.0.4 MECHANISM OF HAEMODYNAMIC RESPONSE          
TO LARYNGOSCOPY       12 
           2.0.5 THE EFFECTS OF GENERAL ANAESTHESIA ON                 
HAEMODYNAMIC DURING INDUCTION AND INTUBATION 13 
  
iv 
  
2.0.5.1 Effects from the drugs manipulation    14 
 2.0.5.2 Effects from the technique of anaesthesia   14 
 2.0.5.3 Effects from the technique of intubation    15 
            2.0.6 IMPACT OF INDUCTION AND INTUBATION TO THE             
HAEMODYNAMIC INSTABILITY      15 
            2.0.7 THE EFFECTS OF TOTAL INTRAVENOUS ANAESTHESIA       
AND TARGET-CONTROLLED INFUSION ON                            
GENERAL ANAESTHESIA              17 
            2.0.8 THE SYSTEMIC EFFECTS OF ANAESTHETIC DRUGS ON   
PHYSIOLOGICAL CHANGES       18  
            2.0.9 CHOICES OF ADJUNCT DURING INDUCTION                 
AND INTUBATION         19 
 2.0.9.1 Lignocaine         19 
 2.0.9.2 Benzodizepine        19 
 2.0.9.3 Beta blocker         20 
 2.0.9.4 Alpha 2-adrenergic receptor agonist     20 
2.1      TOTAL INTRAVENOUS ANAESTHESIA USING                
TARGET-CONTROLLED INFUSION       22 
2.1.1 THE HISTORY         22 
2.1.2 THE PRINCIPLES OF TCI ANAESTHESIA     23 
2.1.3 DRUGS USED IN TIVA        23 
2.1.4 ADVANTAGES AND DISADVANTAGES OF TCI    24 
2.1.5 PHARMACOKINETIC MODELS PREFERENCE    25 
 
 
v 
  
2.1.6 TCI PROPOFOL AND OPIOID      26 
2.2 DEXMEDETOMIDINE        28 
 2.2.1 CHEMICAL STRUCTURE       28 
 2.2.2 PREPARATIONS        28 
 2.2.3 MECHANISM OF ACTION       28 
 2.2.4 THE PROFILES        30 
2.2.5 SIDE EFFECTS        31 
2.2.6 CLINICAL USES        31 
 2.2.6.1 Premedication       32 
 2.2.6.2 Adjunct to general anaesthesia     32 
 2.2.6.3 Haemodynamic controlled during intubation   34 
 2.2.6.4 Sedation in Intensive Care     35 
2.3 REMIFENTANIL         36 
 2.3.1 CHEMICAL STRUCTURE       36 
 2.3.2 FORMULATIONS        36 
 2.3.3 MECHANISM OF ACTION       37 
 2.3.4 THE PROFILES        37 
 2.3.5 SIDE EFFECTS AND DISADVANTAGES    38 
  2.3.5.1 Bradycardia and hypotension     38 
  2.3.5.2 Respiratory depression      39 
  2.3.5.3 Disadvantage       40 
  
 
vi 
  
2.3.6 CLINICAL USES        40 
  2.3.6.1 Intubation        40 
  2.3.6.2 Maintainence       41 
  2.3.6.3 Neuroanaesthesia       41 
  2.3.6.4 Obesity        42 
  2.3.6.5 Total intravenous anaesthesia      42 
2.4 PROPOFOL          43 
 2.4.1 CHEMICAL STRUCTURE       43 
 2.4.2  FORMULATION        43
  
     2.4.3 MECHANISM OF ACTION       44 
 2.4.4 THE PROFILE        44 
 2.4.5 SIDE EFFECTS        46 
 2.4.6 CLINICAL USES        47 
  2.4.6.1 Induction of anaesthesia      47 
  2.4.6.2 Total intravenous anesthesia and     
               Target-controlled infusion      48 
  2.4.6.3 Nonhypnotic therapeutic application    49
   
CHAPTER 3: OBJECTIVES        51 
3.1 General objective         51 
3.2 Specific objectives         51 
3.3 Null hypothesis           52 
vii 
  
CHAPTER 4: METHODOLOGY        53
  
4.1 Study design          53 
4.2 Study sample           53 
      4.2.1 Inclusion criteria         53 
      4.2.2 Exclusion criteria         54 
      4.2.3 Withdrawal criteria        54 
4.3 Sample size          55 
4.4 Study method          55 
4.5 Statistical analysis         59 
CHAPTER 5: RESULTS         60 
5.1 Demographic characteristics        60 
5.2 Target plasma concentration and effect-site concentration      
      of propofol at successful induction of anaesthesia      63 
5.3 Induction time           65
  
5.4 Mean for mean arterial pressure during induction of anaesthesia  66
  
5.5 Changes of heart rate during induction of anaesthesia    70 
5.6 Changes of mean arterial pressure after endotracheal intubation  74 
5.7 Changes of heart rate after endotracheal intubation    77 
5.8 BIS score after intravenous loading dose of dexmedetomidine   79 
5.9 BIS score changes         80 
CHAPTER 6: DISCUSSION        84 
6.1 Demographic characteristic        85 
viii 
  
6.2 Plasma target concentration and effect-site concentration                  
      of propofol during induction of anaesthesia      85 
6.3 Induction time          86 
6.4 Haemodynamic changes during induction of anaesthesia                                                
      and after intubation         88 
6.5 BIS score after loading dexmedetomidine      93 
6.6 BIS score changes         94 
6.7 other issues          96 
CHAPTER 7: CONCLUSION                 100 
REFERENCES            
APPENDICES 
 Appendix A: Data collection sheet 
 Appendix B: Consent in Malay 
 Appendix C: Consent in English 
 Appendix D: ASA classification 
 Appendix E: preparation of the drugs 
 Appendix F: Dexmedetomidine: dosing schedule for concentration 4mcg/ml 
 
 
 
 
 
 
 
ix 
  
LISTS OF TABLE 
 
 
 
Table  Title         Page No. 
5.1.1  General demographic data       60 
5.1.2  Demographic data between the two groups     62
  
5.2.1 Target plasma concentration (Cpt) and effect-site                           
concentration (Ce) of propofol at successful induction    63
  
5.3.1  Induction time        65 
5.4.1.1 Comparison of mean arterial pressure within each            
group based on time (time effect)      66 
5.4.2.1  Mean difference of mean arterial pressure among the           
two groups during induction of anaesthesia         
(treatment-effect)         67 
5.4.3.1 Comparison of mean of mean arterial pressure at           
induction of anaesthesia between the groups based           
on time (time-treatment interaction)     68 
5.5.1.1 Comparison of heart rate within each group based    
  on time during induction of anaesthesia (time-effect)   70 
5.5.2.1 Mean difference of heart rate between the two groups   
  during induction of anaesthesia (treatment-effect)   72 
5.5.3.1 Comparison of mean heart rate between two different              
groups based on time during induction of anaesthesia                    
(time-treatment interaction)      72 
5.6.1.1 Comparison of mean arterial pressure after intubation                                     
within each group based on time after endotracheal                 
intubation (time-effect)       74 
5.6.2.1 Difference of mean arterial pressure after intubation              
between the two groups after endotracheal intubation   75 
x 
  
5.6.3.1  Comparison of mean of mean arterial pressure after      
intubation between the groups based on time        
(time-treatment interaction)      76 
5.7.1.1  Comparison of mean heart rate after intubation           
within each group (time-effect)      77 
5.7.2.1 Mean difference of heart rate after intubation among    
  the two groups (treatment-effect)       78 
5.7.3.1  Comparison of mean heart rate between two different      
groups based on time after endotracheal intubation       
(time-treatment interaction)      78 
5.8.1  BIS score after intravenous loading of dexmedetomidine     79 
5.9.1.1 Comparison of BIS score changes within each group    
  based on time (time-effect)       80 
5.9.2.1  Mean difference of BIS score changes between the            
two groups (treatment-effect)       82 
5.9.3.1 Comparison of mean BIS score between two different             
groups based on time (time-treatment interaction)   82 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
  
LISTS OF FIGURE  
 
 
 
Figure  Title        Page No. 
2.0.2.1 Types of anaesthetic procedures       9 
2.0.2.2 Components of general anaesthesia, those to be                                 
                      achieved and those to be avoided      10 
2.0.3.1  Dates of introduction of anaesthetic drugs    11 
2.2.1.1 Chemical structure of dexmedetomidine      28 
2.2.3.1 Physiology of the alpha 2-adrenoceptor agonist receptor  29 
2.3.1.1 Chemical structure of remifentanil                   36 
2.4.1.1 Chemical structure of propofol        43 
5.4.3.1 Comparison of mean of mean arterial pressure among     
two groups based on time (time-treatment interaction)   69 
5.5.3.1 Comparison of mean heart rate among two different     
groups based on time during induction of anaesthesia      
(time-treatment interaction)      73 
5.9.3.1 Comparison of mean BIS score among two different     
groups based on time (time-treatment interaction)   83 
 
 
 
 
 
 
 
 
 
 
xii 
  
ABBREVIATIONS 
 
 
 
ANOVA Analysis variance  
ASA   American Society of Anaesthesiologist 
ABA   American Board of Anaesthesiology 
BIS  Bispectral index score 
BP  Blood pressure 
bpm  beat per minute 
CI  Confidence interval 
Cpt  Target plasma concentration 
Ce  Effect-site concentration  
ECG  Electrocardiogram 
EEG  Electroencephalography 
ENT  Ear, Nose and Throat  
GABA  Gamma-aminobutyric acid  
GA  general anaesthesia 
HR  Heart rate 
IV  Intravenous 
MAP  Mean arterial pressure 
SD  Standard deviation 
TCI  Target-controlled infusion 
TIVA  Total intravenous anaesthesia 
 
 
 
xiii 
  
ABSTRAK 
 
 
 
KESAN SUNTIKAN UBAT DEXMEDETOMIDINE SEBAGAI UBAT 
PENDAHULUAN KE ATAS PEMBIUSAN YANG MENGGUNAKAN                                                   
UBAT PROPOFOL DAN REMIFENTANIL SECARA SUNTIKAN BERTERUSAN 
(INFUSI KAWALAN SASARAN) 
 
Tujuan: Kajian ini dijalankan untuk melihat kesan pendahuluan ubat dexmedetomidine 
semasa pembiusan bersama infusi kawalan sasaran propofol dan remifentanil ke atas 
proses induksi dan juga ke atas perubahan hemodinamik.    
Tatacara: Seramai lima-puluh empat orang pesakit berstatus ASA I dan II yang dijadualkan 
untuk pembedahan elektif secara pembiusan am dengan intubasi pada trakea telah dipilih. 
Kajian ini dijalankan dalam berbentuk prospektif, rawak, pemerhati-buta, cubaan dalam 
terkawal. Para pesakit dibahagikan kepada dua kumpulan secara rawak. Para pesakit 
kumpulan dex (n=27) menerima dos pendahuluan dexmedetomidine 1 mcg/kg yang 
dialirkan selama 10 minit. Para pesakit kumpulan kontrol (n=27) menerima cecair 0.9% 
normal saline mengikut jumlah isipadu (iaitu bagi 1 mcg/kg dexmedetomidine), yang 
dialirkan selama 10 minit. Pembiusan am kemudiannya dimulakan untuk semua pesakit, 
dimulai dengan aliran infusi kawalan sasaran remifentanil sebagai permulaan 2 ng/ml 
selama satu minit. Seterusnya diikuti dengan aliran infusi kawalan sasaran propofol sebagai 
permulaan 2 mcg/ml. Selepas satu minit, dos propofol akan dinaikkan sebanyak 0.5 mcg/ml 
setiap 30 saat sehingga pesakit mencapai pembiusan optimum; tidur/tidak sedar. Selepas 
xiv 
  
itu pesakit akan diberi suntikan rocuronium sebanyak 0.9 mg/kg dan saluran pernafasannya 
diintubasi selepas satu minit pemberian rocuronium. Selepas proses intubasi, infusi kawalan 
sasaran remifentanil akan dinaikkan sebanyak 1 ng/ml setiap kali, sekiranya kadar degupan 
jantung semakin laju atau/dan tekanan darah semakin meningkat. Kenaikan ini dilakukan 
sehingga kadar degupan jantung dan tekanan darah menjadi lebih stabil. Kepekatan 
propofol di dalam darah, kepekatan propofol pada organ-sasaran, masa untuk proses 
induksi iaitu bermula aliran propofol sehingga pesakit tidur dan jumlah remifentanil yang 
diperlukan untuk menstabilkan parameter jantung selepas intubasi dicatatkan. Tekanan 
darah, purata tekanan darah, kadar degupan jantung  dan skor kesedaran dicatatkan pada T 
permulaan, T selepas dos ubat pendahuluan, T selepas remifentanil, T selepas pesakit 
mencapai tidur, T sebelum intubasi, T 1 minit selepas intubasi dan T 5 minit selepas 
intubasi.  
Keputusan: Kumpulan dex menunjukkan kepekatan propofol di dalam darah yang lebih 
rendah berbanding kumpulan kontrol [2.44 (0.54) vs 4.20 (1.11) mcg/ml, masing-masing; 
p<0.001]. Kepekatan propofol pada organ sasaran juga lebih rendah dalam kumpulan dex 
berbanding kumpulan kontrol [1.60 (0.67) vs 0.67) mcg/ml, masing-masing; p<0.001]. Masa 
induksi lebih singkat dalam kumpulan dex berbanding kumpulan kontrol [71.59 (38.13) vs 
182.48 (62.64) saat, masing-masing; p<0.001]. Semasa induksi, terdapat perbezaan yang 
bererti dalam purata tekanan darah antara dua kumpulan bersandarkan masa; (F=35.64, 
p<0.001). Purata tekanan darah kumpulan dex adalah signifikan lebih rendah berbanding 
kumpulan kontrol pada T selepas remifentanil; [85.93 (CI 95% 80.85, 91.01) vs 94.89 (CI 
95% 89.81, 99.97) mmHg]. Kadar degupan jantung juga menunjukkan perbezaan bererti 
antara dua kumpulan tanpa mengira masa (p=0.002) dan juga perbezaan bererti dalam-
antara kumpulan bersandarkan masa (F=22.38, p<0.001). Purata kadar degupan jantung 
dalam kumpulan dex adalah signifikan lebih rendah berbanding kumpulan kontrol pada T 
selepas dos ubat pendahuluan; [64.48 (CI 95% 59.94, 69.03) vs 81.22 (CI 95% 76.68, 
85.79) bpm] dan pada T selepas remifentanil; [64.00 (CI 95% 59.16, 68.83) vs 79.37 (CI 
xv 
  
95% 74.53, 84.21) bpm]. Selepas intubasi, terdapat perbezaan bererti dalam purata tekanan 
darah antara dua kumpulan tanpa mengira masa (p<0.001). Bagi kadar degupan jantung 
pula, terdapat perbezaan bererti dalam purata kadar degupan jantung tanpa mengira masa 
(p=0.004). Manakala untuk skor kesedaran, terdapat perbezaan bererti dalam purata skor 
kesedaran untuk dalam-antara dua kumpulan bersandarkan masa (F=22.40, p<0.001). 
Purata skor kesedaran kumpulan dex adalah signifikan lebih rendah berbanding kumpulan 
kontrol pada T selepas dos ubat pendahuluan; [87.36, (CI 95% 85.75, 89.90) vs 97.71 
(95.68, 99.74)] dan pada T selepas remifentanil; [83.61 (CI 95% 79.96, 87.26) vs 95.38 (CI 
95% 91.80, 98.95)]. Purata skor kesedaran kumpulan dex adalah signifikan lebih tinggi 
berbanding kumpulan kontrol pada T selepas pesakit mencapai tidur; [72.04 (CI 95% 67.65, 
76.44) vs 63.46 (CI 95% 59.16, 67.76)] dan pada T 5 minit selepas intubasi; [54.00 (CI 95% 
49.36, 58.64) vs 41.54 (CI 95% 37.00, 46.08)]. Tiada perbezaan yang bererti dilihat pada: 
purata tekanan darah antara kedua-dua kumpulan dan kadar degupan jantung pada ‗dalam-
antara‘ kumpulan semasa proses induksi, kadar degupan jantung pada ‗dalam-antara‘ 
kumpulan selepas proses intubasi dan skor kesedaran antara dua kumpulan.        
Kesimpulan: Pemberian ubat permulaan dexmedetomidine mengurangkan dos kepekatan 
propofol di dalam darah dan kepekatan propofol pada organ-sasaran semasa proses 
induksi. Ia juga menurunkan parameter hemodinamik yang stabil semasa proses induksi dan 
proses intubasi saluran pernafasan dan juga memendekkan masa pembiusan.    
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ABSTRACT  
 
 
 
THE EFFECTS OF INTRAVENOUS DEXMEDETOMIDINE                    
PREMEDICATION ON INDUCTION OF ANAESTHESIA USING                      
TARGET-CONTROLLED INFUSION OF PROPOFOL AND REMIFENTANIL 
 
Objective: The aims of this study were to determine the effects of intravenous 
dexmedetomidine premedication on induction of anaesthesia and intubation using TCI 
propofol and TCI remifentanil. 
Methods: 54 respondents, aged 18 to 60 year-old, ASA I – II patients scheduled for elective 
surgeries under general anaesthesia with endotracheal intubation were enrolled in this 
prospective, randomized, observer blinded, controlled clinical trial. They were randomly 
allocated into two groups. Group I: Dex Group (n=27) received infusion loading 
dexmedetomidine 1 mcg/kg over ten minute. Group II: Control Group (n=27) received the 
same calculated volume of 0.9% normal saline solution over ten minute. General 
anaesthesia was induced in both groups with TCI remifentanil starting at 2 ng/ml over one 
minute followed by TCI propofol at target plasma concentration of 2 mcg/ml. After one 
minute, the TCI propofol will be titrated every 0.5 mcg/ml in every 30 second until loss of 
consciousness achieved. After successful induction, intravenous rocuronium 0.9 mg/kg was 
given and intubation done after one minute. After intubation, TCI remifentanil must be tapper 
up by 1 ng/ml if there were any tachycardia and hypertension until stable. The following data 
were recorded; target plasma concentration and effect-site concentration of propofol at 
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successful of induction, the induction time from starting of TCI propofol to loss of 
consciousness and any supplementation of TCI remifentanil after intubation. The following 
parameters were recorded; blood pressure (BP), mean arterial pressure (MAP), heart rate 
(HR) and bispectral index score (BIS) at T baseline, T after completed loading drug study, T 
after TCI remifentanil, T after successful TCI propofol, T before intubate, T 1 minute after 
intubate and T 5 minute after intubate.       
Results: Dex Group showed significantly lower target plasma concentration of propofol than 
control group [2.44 (0.54) vs 4.20 (1.11) mcg/ml; p<0.001]. The effect-site concentration of 
propofol also significantly lower in Dex Group than control group [1.60 (0.67) vs 3.43 (1.09) 
mcg/ml; p<0.001]. Dex Group had significantly shorter induction time compared to control 
group [71.59 (38.13) vs 182.48 (62.64) second; p<0.001]. During induction of anaesthesia, 
there was a significant difference of mean MAP between the two groups based on time; 
(F=35.64, p<0.001). Mean of MAP in Dex Group was significantly lower than control group at 
T after TCI remifentanil; [85.93 (CI 95% 80.85, 91.01) vs 94.89 (CI 95% 89.81, 99.97) 
mmHg]. In term of HR on induction, there were significant differences between the groups 
(p=0.002) regardless of time and within-between the group based on time (F=22.38, 
p<0.001). Mean of HR in Dex Group was significantly lower than control group at T after 
intravenous loading dex; [64.48 (CI 95% 59.94, 69.03) vs 81.22 (CI 95% 76.68, 85.79) bpm] 
and at T after TCI remifentanil; [64.00 (CI 95% 59.16, 68.83) vs 79.37 (CI 95% 74.53, 84.21) 
bpm]. After endotracheal intubation, there were significant differences of mean MAP 
between the two groups (p<0.001) regardless of time. In term of HR after endotracheal 
intubation, there were significant differences of mean HR between the two groups (p=0.004) 
regardless of time. The BIS core was significantly lower in Dex Group compared to control 
group after intravenous loading of dexmedetomidine, [87.83 (7.06) vs 97.70 (0.47); p<0.001]. 
In term of the BIS score changes there was a significant difference of mean BIS score 
within-between the two groups based on time (F=22.40, p<0.001). Mean of BIS score in Dex 
Group was significantly lower than control group at T after intravenous loading 
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dexmedetomidine; [87.36, (CI 95% 85.75, 89.90) vs 97.71 (95.68, 99.74)] and at T after TCI 
remifentanil; [83.61 (CI 95% 79.96, 87.26) vs 95.38 (CI 95% 91.80, 98.95)]. Mean of BIS 
score in Dex Group was significantly higher than control group at T after successful 
induction; [72.04 (CI 95% 67.65, 76.44) vs 63.46 (CI 95% 59.16, 67.76)] and at T 5 minute 
after intubation; [54.00 (CI 95% 49.36, 58.64) vs 41.54 (CI 95% 37.00, 46.08)]. No other 
significant different seen in other parameter; mean of MAP between the two groups and 
mean of HR within-between the group during induction of anaesthesia, mean HR within-
between the group after endotracheal intubation and mean BIS score between the two 
groups.      
Summary: Premedication of dexmedetomidine reduced the requirement of target plasma 
concentration and effect-site concentration of TCI propofol for induction. It also produced 
shortened induction time and more stable haemodynamic changes during induction, as well 
as intubation.   
1 
  
CHAPTER 1: INTRODUCTION 
 
 
 
 Nowadays there are many ways and options to conduct general anaesthesia. Other 
than bolus intravenous induction and inhalational induction, the introduction of total 
intravenous anaesthesia (TIVA) offered another step of induction. The introduction of TIVA 
gives a better understanding on pharmacokinetics of the drugs. This eventually led to the 
introduction of target controlled infusion (TCI). Why the techniques of induction and 
maintenance of anaesthesia is expanding? The aims remain to provide smooth induction 
with minimum haemodynamic changes, at the same time maintaining the adequate depth of 
anaesthesia during the induction and intubation as well as throughout the maintenance and 
extubation period. 
 
 Laryngoscopy and tracheal intubation is a known procedure that most often 
associated with elevation of heart rate and blood pressure due to sympathetic response to 
the manipulation of the airway. These surge of responses have been described by King et al. 
(1951) more than 60 years ago (King et al., 1951). Even though the surge of these 
parameters are transient and might only cause minimum consequence in ASA physical 
status I and young patients, it can cause negative effect in the vulnerable patient (Kovac, 
1996). For the examples are; patients with long standing diabetes mellitus, hypertension, 
high intracranial pressure and cardiac disease. Studies in anaesthetized patients proved that 
sympathetic nerve activity and blood pressure rose rapidly during laryngoscopy and 
intubation (Ebert et al., 1990; Ebert et al., 1992; Sellgren et al., 1992) and it also indirectly 
affected the renal system; as it caused alpha-adrenergic renal vasoconstriction in response 
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to the physiological stress (Conboy et al., 2010; Momen et al., 2005; Momen et al., 2003; 
Sauder et al., 2008). Therefore stimulation of sympathetic excitatory response during 
laryngoscopy and intubation may contribute significantly to perioperative cardiovascular 
morbidity and mortality as well as carry significant risk to other vital organ (Muller et al., 
2013).  
 
 How does this sympathetic response occur during induction, laryngoscopy and 
intubation? In the pharynx, the sensations are innervated by glossopharyngeal nerve and 
the motor aspect is innervated by vagus nerve. For the larynx, the sensory is innervated by 
internal laryngeal nerve and recurrent laryngeal nerve. Its motor innervation is also by 
recurrent laryngeal nerve except for cricothyroid muscle (Ellis, 2004). The mechanism of 
intubation response is based on sympathetic and parasympathetic responses. The 
sympathetic response is a polysynaptic pathway with the glossopharyngeal and vagus nerve 
forming the afferent arch to the sympathetic nervous system via the brainstem and spinal 
cord. Then produced autonomic response at the efferent by increased the firing of the 
cardioaccelerator fibres and release of adrenergic mediator including catecholamine. 
Therefore the summation effects are the rise in blood pressure, heart rate and pulmonary 
artery wedge pressure as well as the decreased in the ejection fraction. The 
parasympathetic reflex is monosynaptic. It is common in children but can still occur in adults. 
The reflex is mediated by increased in vagal tone at the sino-atrial node (Blunting the 
intubation response: Fact or Fiction 2011). Many other studies showed significant 
haemodynamic response throughout laryngoscopy and intubation (Hassan et al., 1991; 
Shribman et al., 1987; Singh and Smith, 2003; Takahashi et al., 2002) with the increment of 
systolic BP up to 41-53mmHg, HR up to 20-23bpm and MAP up to 100% from the baseline 
(King et al., 1951; Perkins et al., 2013). 
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 In 1992, during the World Congress at The Hague, a European task force for TIVA 
was initiated. Since then there was huge expansion of the usage of TIVA into the clinical 
practise parallel with better understanding of pharmacokinetic of intravenous induction 
agent. This eventually led to the introduction of TCI in 1996 according to European Society 
of Intravenous Anaesthesia (EuroSIVA). TIVA is a technique of general anaesthesia using 
combination of agents given solely by the continuous intravenous route and in the absence 
of inhalational agent. In the TIVA it is focused on the concentration of the drugs in the 
plasma. The TCI is also given continuous intravenous route, but it is more precise. TCI is an 
infusion controlled in such manner as to attempt to achieve a user defined drug 
concentration in a body compartment of interest known as effect site concentration 
(Sivasubramaniam, 2007). The software calculates continuously the patient‘s expected drug 
concentration and administers a bolus-elimination-transfer regimen and adjusting the pump 
infusion rates based on weight, height, age and sex of the patient to achieve effect-site 
concentration; in our practice the effect site is the brain. There are many TCI models and 
TCI pumps available (Absalom et al., 2009; Sivasubramaniam, 2007). In this study, we used 
Marsh model targeting plasma concentration for the propofol and Minto model targeting 
effect-site concentration for the remifentanil. The TCI pumps for both drugs are an 
Injectomat TIVA Agilia, manufactured by Fresenius Kabi, Germany. TIVA and TCI 
techniques offer markedly reduce incidence of post-operative nausea and vomiting, more 
predictable with rapid recovery and greater hemodynamic stability. Other than that, it also 
reduces atmospheric pollution, easier to titrate, preservation of hypoxic pulmonary 
vasoconstriction and reduction in intracereberal pressure (College of Anaesthesiologists, 
2013; Yuill and Simpson, 2002).   
 
 Dexmedetomidine is a centrally acting alpha 2-adrenergic receptor agonist. Initially 
manufacturer suggests dexmedetomidine is indicated for two conditions; for conscious-
sedation in non-intubated patient during minor surgical procedures such as cataract surgery 
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and dental surgery or any other clinical procedure such as awake fibreoptic intubation, and 
colonoscopy. Second condition is for sedation in mechanically ventilated patient in intensive 
care for less than 24hours sedation. Nowadays the use of dexmedetomidine has been 
expanding into operation theatre environment as an adjunct in anaesthesia particularly 
during TIVA (García Botero et al., 2011). In general, it has been proven to have the ability to 
blunt the stress response associated with anaesthesia procedures (Talke et al., 2000). When 
dexmedetomidine is infused at doses ranging from 0.25 to 2 mcg/kg over two minute, it 
produced dose dependent sedation with peak sedative effect seen at tenth minute after drug 
administration (Belleville et al., 1992). The main concern of dexmedetomidine effect is on 
cardiovascular system. An infusion of dexmedetomidine from 0.25 to 2 mcg/kg over two 
minute caused a dose dependant decreased about 14% to 27% in arterial BP (Bloor et al., 
1992). There were also decreased in heart rate and cardiac output at the dosage above 0.5 
mcg/kg with reduction of 20% at 1 mcg/kg and 40% at 2 mcg/kg doses (Bloor et al., 1992). 
Dexmedetomidine produces a reduction in systemic sympathetic tone with preserved 
baroreceptor activity and sensitivity (Hogue Jr et al., 2002). Other advantages of 
dexmedetomidine; it has shown efficacy in decreasing the needs for opioids, 
benzodiazepines and propofol (Arcangeli et al., 2009).  
 
 Propofol, 2,6-diisopropylphenol, is an intravenous anaesthetic agent, used primarily 
for induction in general anaesthesia and for the maintenance of anaesthesia. The context-
sensitive half- time is 20min even after eight hour of infusion (Evers et al., 2011). The 
context-sensitive half-time of propofol is minimally influenced by the duration of infusion 
because of rapid metabolic clearance after infusion is discontinued. Infusion propofol in 
combination with short acting opioid has proved to be a valuable adjuvant during short 
ambulatory procedures. General anaesthesia with propofol associated with very minimal 
post-operative nausea and vomiting and minimal residual sedative effects. The effect of 
propofol on the cardiovascular system, i.e significantly decreases systemic BP, is more than 
5 
  
that evoked by comparable doses of thiopental. There is no protective effects on the 
haemodynamics during stimulation from direct laryngoscopy and intubation. According to the 
College of Anaesthesiologist (2013) the recommended target concentration for induction of 
anaesthesia for propofol starts at 4 mcg/ml and titrable till up to loss of consciousness and 
followed by maintenance 2 to 6 mcg/ml. This target concentration is applicable for individual 
less than 90kg, not more than 65 years old and ASA I and II. 
 
 Remifentanil is a mu-agonist opioid. It is an ultra-short acting opioid. It is rapidly 
hydrolysed by red cell and tissue esterases. Remifentanil has a low volume of distribution, 
400ml/kg but the clearance is high, 40-45ml/kg/min. Therefore its elimination half-life is 
extremely short, eight to ten minute without accumulative effects. The context-sensitive half-
time is three to five minute, more rapid than any other opioid. Since it has rapid offset, it 
must be given by continuous infusion (Calvey and Williams, 2009). Anaesthesia can be 
induced by administration of 1 mcg/kg over 60 to 90 second (Stoelting and Hillier, 2006). If 
rapid bolus given, it can cause marked bradycardia, hypotension and chest wall rigidity. 
Based on College of Anaesthesiologist (2013), for the TCI to start at 2 ng/ml and increase to 
3 ng/ml before intubation and maintenance 1 to 8 ng/ml. For the TIVA, 1 mcg/kg over 60 to 
90 second then maintenance 0.1 to 1 mcg/kg/min. 
 
 
 
 
 
 
6 
  
 For this study, we wanted to assess the effects of intravenous dexmedetomidine 
premedication on induction of anaesthesia using target-controlled infusion of propofol and 
remifentanil and haemodynamic changes during intubation in patient undergoing surgical 
procedure under general anaesthesia. Specifically, we would like to look into the target 
plasma concentration and effect-site concentration of propofol at successful induction of 
anaesthesia after intravenous loading dose of dexmedetomidine between the two groups 
and the induction time between the two groups. We also wish to see the haemodynamic 
changes during induction of anaesthesia and after endotracheal intubation. The last 
objective in this study is to observe the BIS score changes throughout induction and 
intubation procedures.  
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CHAPTER 2: LITERATURE REVIEW 
 
 
2.0 INTRODUCTION OF ANAESTHESIA  
In the community perspective, going for surgery is equivalent to going for sleep due 
to the anaesthetic medications and its technique.  
 
2.0.1 THE HISTORY AND DEFINITION OF ANAESTHESIA  
Modern anaesthesia is said to have begun with the successful demonstration of 
etherization by William Morten in October 16, 1846 at the Massachusetts General Hospital, 
Boston. He as a dentist, administered diethyl ether to Edward Abbott for the excision of a 
tumor for his neck. Together with William Marton were Hickman, Wells, Davy and Long 
(Bovill, 2008; Cottineau et al., 1998).   
 
Inhalational anaesthesia rapidly became common for surgery; with ether, nitrous 
oxide and chloroform. These agents predominated the anaesthetic world until the 
development of organic fluorine chemistry in the 1950s. Introduction of fluorine paved the 
way for the synthesis of the fluorinated anaesthetic alkanes and ethers used in modern 
anaesthesia.  
 
The word ‗etherization‘ was used during initial introduction of anaesthesia. It then 
replaced with the terms anaesthesia and narcosis ( a Greek word for loss of sensation or 
without feeling and stupor or paralysis, respectively) (Bovill, 2008; Urban and Bleckwenn, 
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2002). The expansion of definitions then well-established later by Woodbridge Antognini and 
Overton (Urban and Bleckwenn, 2002).   
 
In the modern era, the definition of anaesthesiology provided by American Board of 
Anaesthesiology (ABA), states that anaesthesiology is the practice of medicine providing 
insensibility to pain during surgical, obstetric, therapeutic and diagnostic procedures. The 
insensibility to pain may be provided by local anaesthetic, regional anaesthetic or general 
anaesthesia (GA).  
 
According to ABA, GA is defined as a drug-induced loss of consciousness during 
which patients are not arousable, even by painful stimulation. The ability to independently 
maintain ventilator function is often impaired.  Patients often require assistance in 
maintaining a patent airway, with positive pressure ventilation required due to depressed 
spontaneous ventilation or drug induced depression of neuromuscular function. The 
cardiovascular function may also be impaired.  
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2.0.2 TYPES OF ANAESTHESIA AND THE AIMS DURING GENERAL ANAESTHESIA 
There are many types of anaesthesia as seen in Figure 2.3.1.   
 
Figure 2.0.2.1: Types of anaesthetic procedures  
From: Urban and Bleckwenn 2002. Concepts and correlation relevant to general 
anaesthesia. British Journal of Anaesthesia, 89 (1):3-16 
 
In our study, we focus on GA that requires endotracheal intubation. The concern is to 
achieve and keep smooth induction and maintain stable haemodynamic changes (Urban and 
Bleckwenn, 2002). Figure 2.0.2.2 summarized the aim during GA, hence minimizing the 
potentially harmful direct and indirect effects of anaesthetic agents and techniques and at 
the same time, sustaining physiologic homeostasis during surgical procedures for good post-
operative outcomes.  
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Figure 2.0.2.2: Components of general anaesthesia, those to be achieved and those to be 
avoided.  
Analgesia has been put in brackets because it is already included in other categories; if pain 
is defined as conscious awareness of a noxious stimulus, then unconscious patient may not 
perceive pain. Immobility includes the abolition of spontaneous movement.  
From: Urban and Bleckwenn 2002. Concepts and correlation relevant to general 
anaesthesia. British Journal of Anaesthesia, 89 (1):3-16  
 
 
2.0.3 GENERAL ANAESTHETIC AGENTS IN CLINICAL USE 
Since introduction of ether, there have been other varieties of anaesthetic drugs that 
have been introduced, as seen in Figure 2.0.3.1  They consist of halogenated ethers; 
sevoflurane, desflurane, isoflurane, enflurane, the halogenated alkane; halothane, nitrous 
oxide, intravenous induction agents; barbiturates, benzodiazepines, etomidate and analgesic 
(Evers et al., 2011; Urban and Bleckwenn, 2002).   
 
None of the above agents can be used as a single agent to provide anaesthesia. The 
inhalational agents lack analgesia potency and may even possess hyperalgesic properties 
(Zhang et al., 2000). The intravenous anaesthetic agent also lack analgesia potency; with 
11 
  
propofol being known to cause pain during injection. As a result, multiple co-administration of 
drugs are given to provide good GA; the hypnotic drug, the analgesic drug and a muscle 
relaxant.  
 
            
Figure 2.0.3.1 Dates of introduction of anaesthetic drugs  
From Urban and Bleckwenn 2002. Concepts and correlation relevant to general 
anaesthesia. British Journal of Anaesthesia, 89 (1):3-16  
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2.0.4 MECHANISM OF HAEMODYNAMIC RESPONSE TO LARYNGOSCOPY  
Let us revise the anatomy of the airways and the mechanism of intubation response. 
In the pharynx, the sensory is innervated by glossopharyngeal nerve and the motor is 
innervated by vagus nerve. In the larynx the sensory is innervated by internal laryngeal 
nerve and recurrent laryngeal nerve. The motor innervation of the larynx  is also by recurrent 
laryngeal nerve except for cricothyroid muscle (Ellis, 2004). The mechanism of intubation 
response is based on sympathetic and parasympathetic response. The sympathetic 
response is a polysynaptic pathway with the glossopharyngeal and vagus nerve forming the 
afferent arch to the sympathetic nervous system via the brainstem and spinal cord. Then 
they produced autonomic response at the efferent by increased the firing of the 
cardioaccelerator fibres and release of adrenergic mediators including catecholamine. 
Therefore the summation effects are rise in BP, HR and pulmonary artery wedge pressure 
with decreased ejection fraction. The parasympathetic reflex is monosynaptic. It is common 
in children population but still can occur in adult population. The reflex is mediated by 
increased in vagal tone at the sino-atrial node (Blunting the intubation response: Fact or 
Fiction 2011). 
 
According to King et al. (1951) the haemodynamic changes was due to either 
decreased vagal tone or increased sympathoadrenal activity. They found that it was easier 
to block the response of BP than the increment in the HR. The laryngoscopy without 
intubation alone can increased BP effect and this response augmented with intubation is 
unfortunately capable of produce arrhythmia (King et al., 1951).  
 
The cardiovascular response to the laryngoscopy and intubation not only involves 
central nervous system (CNS) but also by increased adrenomedullary catecholamine activity 
(Bedford, 1988; Derbyshire et al., 1983; Derbyshire et al., 1987). Apart from explanation of 
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the CNS role, there also effects of polysynaptic pathways which cause the release of 
noradrenaline from adrenergic nerve terminals in vascular beds and release of adrenaline 
from the adrenal medulla. Derbyshire et al. (1983) also highlighted the possible involvement 
of renal role: release of renin from the juxtaglomerular apparatus cause activation of renin-
angiotensin system which may contribute to the hypertensive response during tracheal 
intubation.  
 
There was a study done separating the response to laryngoscopy and the act of 
endotracheal intubation (Ovassapian et al., 1983). The study reported maximum increase in 
BP and HR occurred during placement of endotracheal tube in the trachea. Another similar 
study also found significant elevation of BP and catecholamine in laryngoscopy with or 
without intubation with HR increased further during intubation (Shribman et al., 1987). 
 
2.0.5 THE EFFECTS OF GENERAL ANAESTHESIA ON HAEMODYNAMIC DURING 
INDUCTION AND INTUBATION 
Many studies had been done regarding haemodynamic impact during induction and 
intubation in relation to either pharmacological agents or techniques of anaesthesia and 
intubation. 
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2.0.5.1 Effects from the drugs manipulation  
A comparison was made between opioid and beta blocker to obtund the sympathetic 
reflex during intubation. Bolus injection of fentanyl 2 mg/kg failed to prevent elevation of HR 
and BP, whereas esmolol 2 mg/kg was able to maintain HR but not the BP (Hussain and 
Sultan, 2005). In study by Rathore et al. (2002) with different doses of esmolol to obtund 
sympathetic reflex during laryngoscopy showed a rise in HR and systolic pressure at two 
minute intubation in all groups. The only significant group was esmolol 150mg, which was 
the highest dose in the study, to keep minimum elevation in haemodynamic changes at two 
minute intubation (Rathore et al., 2002). A comparative study between two opioids on 
haemodynamic changes during intubation was done (Sharma and Parikh, 2014). There is 
increased in systolic pressure, diastolic pressure and HR at intubation in both groups; 
nalbuphine and fentanyl. However the rise was more in nalbuphine group than fentanyl 
group for the BP, but not in the HR. They concluded the elevation of HR was not significant 
in both groups (Sharma and Parikh, 2014).   
 
2.0.5.2 Effects from the technique of anaesthesia 
A study from Thailand on effect of propofol induction by manual bolus injection 
versus target controlled-infusion (Taweesangsuksakul, 2010). He reported that there were 
no significance difference in haemodynamic parameters during intubation by target-
controlled infusion and manual bolus infusion despite dose of induction by target controlled 
infusion was much more than manual bolus infusion.   
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2.0.5.3 Effects from the technique of intubation  
Airway manipulation by direct laryngoscopy and intubation are known to induce 
clinical changes in haemodynamic parameter. These procedures are among the most painful 
process during anaesthesia associated with haemodynamic response which can last at least 
10 minute (Barak et al., 2003; Bruder et al., 1991; Malde and Sarode, 2007; McNicol et al., 
2011). Throughout these procedures, there is sympathoadrenal stimulation and causing 
release of catecholamine which cause surge of HR and BP. This causes alteration in 
hemodynamic up to more than 30% from the baseline (Edwards et al., 1994; Kovac, 1996).   
 
Tabari et al. (2013), comparing intubation by direct laryngoscopy and intubating 
laryngeal mask showed: there were rises of BP and MAP in both groups but no differences 
seen in both group when compared to after intubation (Tabari et al., 2013). Bennett et al. 
(2004) reported MAP increased at intubation in the tracheal intubation group and in the 
intubating LMA (ILMA) group but not in the LMA group. There were also rises in HR but the 
changes were not significant (Bennett et al., 2004).             
 
2.0.6 IMPACT OF INDUCTION AND INTUBATION TO THE HAEMODYNAMIC 
INSTABILITY  
Even though haemodynamic response does not present a problem for most of the 
patients, in subgroup particularly with cardiovascular and cerebral diseases may increase 
risk of mortality and morbidity from acute tachycardia and hypertension resulting from the 
stress of laryngoscopy and endotracheal intubation (Roy et al., 1979; Thomson, 1989). 
Kovac (1996) in his report mentioned that few studies support that controlling peri-operative 
stress, induction and intubation included,  improved outcomes in high risk patients (Giles et 
al., 1982; Moffitt et al., 1985; Slogoff and Keats, 1985).  
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Activation of sympathetic response can cause hypertension, tachycardia, arryhtmia, 
increased intracranial pressure and increased intraocular pressure (Divatia and Bhowmick, 
2005; Mort, 2004). The hypertensive response during endotracheal intubation possessed 
harmful effects in patient with cardiovascular disease, high intracranial pressure, 
hypertension and anomalies of cerebral vessels (Gurulingappa et al., 2012). These 
populations, they might predispose to hypertensive crisis and emergency, cerebral 
haemorrhage, myocardial ischemia and infarct, arrhythmia, cardiac failure and pulmonary 
edema. Slogoff & Keats (1985) also reported that most ischaemic episode during 
anaesthesia were associated with intubation and surgical stimulation especially if presence 
of tachycardia. Tachycardia and hypertension were two dynamic predictors for perioperative 
cardiac morbidity (Kaplan, 1987). It is because both HR and BP are primary determinant of 
balance between myocardial oxygen supply and demand (Kaplan, 1987; Moffitt et al., 1985). 
Stimulation of HR and BP during laryngoscopy and intubation affect the myocardial oxygen 
supply and oxygen demand by increased the demand which unable to meet the supply. 
Additional effect by acute hypertension; peak systolic ventricle pressure increases, 
producing commensurate increase in ventricular demand which further increase myocardial 
oxygen consumption (Giles et al., 1982; Kaplan, 1987).  
 
A study was done to see the haemodynamic changes and catecholamine response 
during intubation in spinal cord injury patient (Yoo et al., 2001). The spinal cord injuries then 
divided into different level of injury. After tracheal intubation, systolic arterial pressure was 
increased significantly in control group (33%), high paraplegic (28%) and low paraplegic 
(39%) and the rose was persisted until two minute after intubation. HR also increased 
significantly after induction and further increased in response to tracheal intubation. However 
incidence of hypotension and bradycardia was very small and not significant. The level of 
plasma noradrenaline concentration in all group were increased significantly but no 
significant changes in plasma adrenaline concentration after intubation (Yoo et al., 2001).   
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2.0.7 THE EFFECTS OF TOTAL INTRAVENOUS ANAESTHESIA AND TARGET-
CONTROLLED INFUSION ON GENERAL ANAESTHESIA 
The TIVA infusion system allows us to select the target blood or site concentration 
required for a particular effect individually. Such as, to achieved loss of consciousness, to 
achieve adequate analgesia level and to keep patient calm and cooperative during 
monitored-sedation anaesthesia.    
 
Russell (1998) comparing manual infusion scheme and target-controlled infusion 
(TCI) system for propofol. Anaesthesia is induced more rapidly with the TCI system and the 
laryngeal mask airway insertion is inserted earlier in these patients. Patient anaesthetized 
with TCI tended to move less both in the response to the initial surgical stimulus and 
subsequent procedure (Russell, 1998).  
 
Level of anaesthesia is deeper in TCI system compared to manual infusion. This can 
be due to larger amount of propofol administration during induction and maintenance in TCI. 
However this will lead to increased respiratory depression compared to manual infusion. 
Otherwise the haemodynamic variables are similar in both groups (Russell, 1998).  
An intervention review in TCI versus manual continuous infusion of propofol for GA 
and sedation in adult does not find sufficient evidences to see any difference in the quality of 
anaesthesia and sedation or the adverse events (Leslie et al., 2008).  
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2.0.8 THE SYSTEMIC EFFECTS OF ANAESTHETIC DRUGS ON PHYSIOLOGICAL 
CHANGES 
GA can lead to variable physiological changes involving multi-systems. The changes 
vary with the drugs used. Therefore different agents possess different clinical outcome. In 
general, intravenous and volatile agents all reduce BP as a result of vasodilatation and 
negative inotropy and chronotrophy (Calvey and Williams, 2009; Stoelting and Hillier, 2012).   
 
The intubation procedure can stimulate sympathetic reflex and release the 
catecholamine which can lead to acute hypertension and tachycardia. The positive pressure 
ventilation can impede venous return to the heart, therefore reducing the preload and 
cardiac output.  
 
The drugs also cause respiratory depressant and depress the airway reflexes 
particularly by intravenous induction agents and volatile agents. Propofol is very effective at 
inducing apnoe and depressing the airway reflexes, facilitating placement of supraglotic 
airway devices (Bovill, 2008).  
 
Other than depressant effect, some drugs can be used as cardiovascular 
preservation. Ketamine maintain cardiovascular stability, preserve the muscular tone and 
preserve the airway patency. Etomidate also useful in cardiovascular instability however its 
depression effect on adrenal limits its use.  
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2.0.9 CHOICES OF ADJUNCT DURING INDUCTION AND INTUBATION 
2.0.9.1 Lignocaine 
Lignocaine is a local anaesthetic (LA). It also used as antiarrhythmic agent, 
bronchodilator, intravenous analgesia and airway anaesthesia (Stoelting and Hillier, 2012). A 
systematic review of randomized control trial was done on efficacy of intravenous lignocaine 
versus placebo on attenuating cardiovascular response to laryngospasm and tracheal 
intubation (Qi et al., 2013). The intravenous lignocaine is useful to attenuate the 
cardiovascular response to intubation compared to placebo group. The decrease in pressure 
response induced by lignocaine is about 20 mmHg and HR is about 15 bpm.  
 
2.0.9.2 Benzodizepine 
Benzodizepines are used for sedation rather than GA due to its prolonged amnesia 
and sedation effects. As adjuvant, benzodiazepines are used for anxiolytics, amnestic and 
sedation pre induction or even during induction. The commonly used benzodiazepine is 
midazolam.  
Cressey et al. (2001) studied on effect of midazolam pre-treatment on induction dose 
requirement of propofol. Pre-treatment with midazolam produced significant reduction in 
propofol requirement in both young and older age group. The older population required 
significant lower dose of propofol compared to young population. However no demonstrable 
benefit seen in cardiovascular stability or the incidence of apnoe (Cressey et al., 2001). 
Combination of lignocaine with fentanyl did not show any benefit over fentanyl alone in 
inhibition of haemodynamic response (Hassani et al., 2013).  
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2.0.9.3 Beta blockers 
The common drug uses is esmolol due to its short acting. It can prevent the reflex 
sympathoadrenal discharge-mediated tachycardia and hypertension during laryngoscopy 
and intubation (Oxorn et al., 1990). A study was done to compare the effectiveness of single 
bolus dose of esmolol or fentanyl in attenuating the haemodynamic response during 
laryngoscopy and endotracheal intubation. Esmolol group provide constant and reliable 
protection against the HR but not the BP (Hussain and Sultan, 2005).  
Same observation seen in the study by Gupta & Tank (2011), on comparing esmolol 
and fentanyl effects to the haemodynamic parameter. The esmolol single bolus successfully 
attenuated the parameter response particularly the HR but the BP showed a rise although it 
was less than in other group after laryngoscopy and endotracheal intubation (Gupta and 
Tank, 2011).  
 
2.0.9.4 Alpha2-adrenergic receptor agonist 
A clonidine exerts its haemodynamic effects on both peripheral and central. 
Peripheral stimulation of subendothelial receptors causes vasoconstriction and on peripheral 
sympathetic nervous system nerve endings inhibit release of noredrenaline. Centrally, it 
stimulate alpha 2-adrenergic inhibitory neuron, therefore reduce sympathetic nervous 
system outflow from CNS to peripheral tissue. As the result, it produces peripheral 
vasodilatation and decrease in systemic BP, HR and cardiac output.  
 
Comparing was made between clonidine and fentanyl on attenuating the 
haemodynamic response during laryngoscopy (Gupta et al., 2013). Clonidine is superior to 
fentanyl in attenuating the haemodynamic response of laryngoscopy and intraoperative 
haemodynamic stability.  
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Agrawal et al. (2014) showed a different perspective of clonidine usage during 
induction. The study is comparing the efficacy of midazolam and clonidine on BIS guided 
anaesthetic induction (Agrawal et al., 2014). Both provide a beneficial effect on 
haemodynamic and reduction in induction of propofol. Clonidine group however offer 
effective in preventing post-operative shivering.                           
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2.1 TOTAL INTRAVENOUS ANAESTHESIA USING TARGET-CONTROLLED INFUSION 
TIVA is based on the principle that a plasma concentration needed to produce 
anaesthesia has to be reached quickly and maintained over the period of time that 
anaesthesia is planned. A loading dose is determined by volume of distribution and the initial 
plasma drug concentration. The infusion rate is determined by the clearance of the drug and 
the plasma drug concentration in plasma.  Lightening of the anaesthetic plane can be 
overcome by intravenous bolus of additional drug. A TCI is an infusion controlled in such 
manner as to attempt to achieve a user defined drug concentration in a body compartment of 
interest or tissue of interest. 
   
2.1.1 THE HISTORY 
A report on propofol infusion is available since 1982. Its describing the use of 
propofol infusions for the maintenance of anaesthesia, then the term TIVA being 
subsequently applied to this technique (Major et al., 1982). Increased in understanding 
facilitated the development of guidelines for the manual administration of propofol by 
intravenous infusion to induce and maintain GA in adult practice (Roberts et al., 1988). The 
traditional practice of the infusion regime for propofol by the Roberts method: 1.5mg/kg 
loading followed by infusion of 10mg/kg/hr, reduced to rate of 8 and 6mg/kg/hr at ten 
minutes interval. The concept of ‗target‘ plasma concentration for propofol was introduced in 
1989 and this actually expanding the development of TCI system (Tackley et al., 1989).    
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2.1.2 THE PRINCIPLES OF TCI ANAESTHESIA 
The TCI pumps are computer controlled syringe drivers which aim to electronically 
replicate the principles of bolus-elimination-transfer regimen by constantly adjusting the 
infusion rate to maintain the desired plasma concentration as selected by the anaesthetist. 
The pharmacokinetic models in TCI is attempted to describe the relationship between dose 
and plasma concentration with respect to time. It was a mathematical model, used to predict 
the blood concentration profile of a drug after a bolus dose or after infusion of varying 
duration. The TCI devices deliver a similar initial bolus and at high infusion rate but as the 
duration of infusion increases, the rate of delivery automatically progressively reduces to 
prevent excess accumulation (McCormack, 2008).    
 
2.1.3 DRUGS USED IN TIVA 
Drugs used for TIVA should possess most if not all of the following properties; water 
soluble to minimized toxicity from the solvent, stable in solution, no perivascular sloughing if 
extravasated, allowable to be given in concentrated solution to avoid fluid overloading, not 
absorbed by the plastics, does not promote bacterial growth, rapid onset of action, cleared 
rapidly from the body for a more rapid and predictable recovery, potent and lipid-soluble and 
chemically compatible with other drugs. There is no single agent that possesses all these 
properties. The common induction agent used is propofol and the common opioids are 
remifentanil, alfentanil and fentanyl.   
 
Thiopental is not suitable for TIVA because of prolonged recovery associated with 
longer infusions. Ketamine has some active metabolites and will accumulate, resulting in 
prolonged drug action. Etomidate has good cardiopulmonary function but it possess several 
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detrimental effects for infusion. It suppresses the production of cortisol. Etomidate has high 
concentration of propylene glycol causes haemolysis resulting in haemoglobinuria.    
 
2.1.4 ADVANTAGES AND DISADVANTAGES OF TCI 
The advantages of TCI are low incidence of post-operative nausea and vomiting 
(PONV), fast emergence, easier to titrate to desired effects and environmental friendly. The 
propofol has its own, intrinsic, antiemetic properties and rapid clearance of remifentanil, the 
incidence of PONV in TCI patients is very small. From the IMPACT study, comparing TIVA 
and inhalation anaesthetic, the incidence of PONV after inhalational increases with the 
length of exposure. Whereby the TIVA is low risk of PONV and not influenced by the length 
of anaesthetic hours. TCI allow fast emergence as the half-time of remifentanil is very short 
and the propofol itself does not accumulate after infusion.  
 
The disadvantage of TCI is related to practical rather than pharmacological 
application. In most countries propofol is more expensive than volatile anaesthetic agents. 
The most obvious disadvantage is the requirement of intravenous access prior to induction 
of anaesthesia. This is not feasible in difficult intravenous access patient for example; post-
radiotherapy and -chemotherapy patient, skin disease patient and pediatric population 
(McCormack, 2008).    
 
 
 
 
 
